ASSOCIATE SCIENTIST I, Molecular Discovery
Biogen Idec - Cambridge, MA

This job posting is no longer available on Biogen Idec. Find similar jobs: Associate Scientist jobs - Biogen Idec jobs

A member of the newly created Molecular Discovery Group within the Immunology Research Department, the successful candidate will be conducting target identification and validation-related research activities in disease areas such as inflammation, autoimmunity and fibrosis.

Perform target identification and validation-related research activities, using both in vitro and in vivo experimental approaches
Design experiments and analyze results
Prepare and deliver internal scientific presentations (both within the Molecular Discovery Group and within the Immunology Research Department)

*LI-RD1

Location
US-MA-Cambridge

Job Category
Research & Preclinical Development

Requisition Number
19055BR

Qualifications
The Department of Immunology Research seeks a highly motivated basic research associate scientist to conduct target identification and validation-related research activities. The successful candidate will have a good understanding in basic immunology principles and is expected to be proficient in technical skills commonly used for immunology research, including flow cytometry and cell culture. Candidates with prior research experience in target identification and validation research approaches, such as siRNA screening and/or animal modeling of immunological diseases, are highly desired. The position requires excellent communication skills, and the ability and willingness to work effectively in a highly collaborative research environment.

Ability to collaborate and work with others in a matrixed environment
Ability to both conduct independent research and being a team player
Desire and ability to further expand scientific knowledge and technical skills

Education
Bachelor’s degree in Biological Sciences with 5 years of research experience, or
Master’s degree in Biological Sciences with 3 years of research experience

About this company
93 reviews
Biogen (NASDAQ: BIIB) is a global leader in the discovery, development and delivery of innovative therapies to improve the lives of...